| Jacob Abraham, MD | |
|
3520 Piedmont Rd Ne, Suite 250, Atlanta, GA 30305-1516 | |
| (404) 870-2802 | |
| (404) 419-6623 |
| Full Name | Jacob Abraham |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 25 Years |
| Location | 3520 Piedmont Rd Ne, Atlanta, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144271800 | NPI | - | NPPES |
| 242113660 | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 056014 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Hospital - Anderson Campus | Easton, PA | Hospital |
| St Luke's Hospital Bethlehem | Bethlehem, PA | Hospital |
| St Luke's Hospital - Monroe Campus | Stroudsburg, PA | Hospital |
| Geisinger St. Luke's Hospital | Orwigsburg, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Progressive Physician Assoc Inc | 1355243809 | 118 |
News Archive
Standard Register today announced its financial results for the fourth quarter and full year 2011. The Company reported revenue of $161.4 million and a net loss of $95.5 million, or $3.28 per diluted share for the fourth quarter of 2011.
Dedication, teamwork, and commitment between Encore Health Resources and Doctors Hospital at Renaissance (DHR) to implement a first-rate, cross-enterprise electronic medical record (EMR) system at the award-winning, Rio Grande Valley health system has earned DHR a high ranking on the Health Information Management & Systems Society (HIMSS) U.S. EMR Adoption Model. From its beginning through "go-live" across DHR's care facilities, the EMR implementation required less than 14 months to successfully accomplish.
ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that it has engaged the Baruch S. Blumberg Institute, the non-profit research sister organization of the Hepatitis B Foundation, to conduct a series of experiments using ContraVir's hepatitis B program, CMX157.
Large-scale food scares like BSE and dioxin-contaminated eggs raised awareness about the health risks posed when a link in the food chain becomes compromised.
The clinical phenotype of COVID-19, caused by SARS-CoV-2, is remarkable for its wide range of severity among individual patients. Genetic variations are known to mediate part of these differences. To examine these differences, researchers in a new study used human induced pluripotent stem cells (iPSCs) from different genetically diverse individuals. These cells are used to model genetic disease since they contain the donor's genetic information. Researchers use a panel of iPSCs from over 500 individuals. The researchers preferred undifferentiated iPSCs to reduce the time required to differentiate them, especially since infection is not always reliable.
› Verified 1 days ago
| Entity Name | Quantum Medical Radiology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164475869 PECOS PAC ID: 3577468040 Enrollment ID: O20031211000366 |
News Archive
Standard Register today announced its financial results for the fourth quarter and full year 2011. The Company reported revenue of $161.4 million and a net loss of $95.5 million, or $3.28 per diluted share for the fourth quarter of 2011.
Dedication, teamwork, and commitment between Encore Health Resources and Doctors Hospital at Renaissance (DHR) to implement a first-rate, cross-enterprise electronic medical record (EMR) system at the award-winning, Rio Grande Valley health system has earned DHR a high ranking on the Health Information Management & Systems Society (HIMSS) U.S. EMR Adoption Model. From its beginning through "go-live" across DHR's care facilities, the EMR implementation required less than 14 months to successfully accomplish.
ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that it has engaged the Baruch S. Blumberg Institute, the non-profit research sister organization of the Hepatitis B Foundation, to conduct a series of experiments using ContraVir's hepatitis B program, CMX157.
Large-scale food scares like BSE and dioxin-contaminated eggs raised awareness about the health risks posed when a link in the food chain becomes compromised.
The clinical phenotype of COVID-19, caused by SARS-CoV-2, is remarkable for its wide range of severity among individual patients. Genetic variations are known to mediate part of these differences. To examine these differences, researchers in a new study used human induced pluripotent stem cells (iPSCs) from different genetically diverse individuals. These cells are used to model genetic disease since they contain the donor's genetic information. Researchers use a panel of iPSCs from over 500 individuals. The researchers preferred undifferentiated iPSCs to reduce the time required to differentiate them, especially since infection is not always reliable.
› Verified 1 days ago
| Entity Name | Clinch County Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861478851 PECOS PAC ID: 7416849922 Enrollment ID: O20040329000922 |
News Archive
Standard Register today announced its financial results for the fourth quarter and full year 2011. The Company reported revenue of $161.4 million and a net loss of $95.5 million, or $3.28 per diluted share for the fourth quarter of 2011.
Dedication, teamwork, and commitment between Encore Health Resources and Doctors Hospital at Renaissance (DHR) to implement a first-rate, cross-enterprise electronic medical record (EMR) system at the award-winning, Rio Grande Valley health system has earned DHR a high ranking on the Health Information Management & Systems Society (HIMSS) U.S. EMR Adoption Model. From its beginning through "go-live" across DHR's care facilities, the EMR implementation required less than 14 months to successfully accomplish.
ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that it has engaged the Baruch S. Blumberg Institute, the non-profit research sister organization of the Hepatitis B Foundation, to conduct a series of experiments using ContraVir's hepatitis B program, CMX157.
Large-scale food scares like BSE and dioxin-contaminated eggs raised awareness about the health risks posed when a link in the food chain becomes compromised.
The clinical phenotype of COVID-19, caused by SARS-CoV-2, is remarkable for its wide range of severity among individual patients. Genetic variations are known to mediate part of these differences. To examine these differences, researchers in a new study used human induced pluripotent stem cells (iPSCs) from different genetically diverse individuals. These cells are used to model genetic disease since they contain the donor's genetic information. Researchers use a panel of iPSCs from over 500 individuals. The researchers preferred undifferentiated iPSCs to reduce the time required to differentiate them, especially since infection is not always reliable.
› Verified 1 days ago
| Entity Name | Atlantic Diagnostic Center Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255373023 PECOS PAC ID: 2668446030 Enrollment ID: O20041111000869 |
News Archive
Standard Register today announced its financial results for the fourth quarter and full year 2011. The Company reported revenue of $161.4 million and a net loss of $95.5 million, or $3.28 per diluted share for the fourth quarter of 2011.
Dedication, teamwork, and commitment between Encore Health Resources and Doctors Hospital at Renaissance (DHR) to implement a first-rate, cross-enterprise electronic medical record (EMR) system at the award-winning, Rio Grande Valley health system has earned DHR a high ranking on the Health Information Management & Systems Society (HIMSS) U.S. EMR Adoption Model. From its beginning through "go-live" across DHR's care facilities, the EMR implementation required less than 14 months to successfully accomplish.
ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that it has engaged the Baruch S. Blumberg Institute, the non-profit research sister organization of the Hepatitis B Foundation, to conduct a series of experiments using ContraVir's hepatitis B program, CMX157.
Large-scale food scares like BSE and dioxin-contaminated eggs raised awareness about the health risks posed when a link in the food chain becomes compromised.
The clinical phenotype of COVID-19, caused by SARS-CoV-2, is remarkable for its wide range of severity among individual patients. Genetic variations are known to mediate part of these differences. To examine these differences, researchers in a new study used human induced pluripotent stem cells (iPSCs) from different genetically diverse individuals. These cells are used to model genetic disease since they contain the donor's genetic information. Researchers use a panel of iPSCs from over 500 individuals. The researchers preferred undifferentiated iPSCs to reduce the time required to differentiate them, especially since infection is not always reliable.
› Verified 1 days ago
| Entity Name | Ctca Physicians Group Of Georgia, Llc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447520333 PECOS PAC ID: 4880841212 Enrollment ID: O20120820001117 |
News Archive
Standard Register today announced its financial results for the fourth quarter and full year 2011. The Company reported revenue of $161.4 million and a net loss of $95.5 million, or $3.28 per diluted share for the fourth quarter of 2011.
Dedication, teamwork, and commitment between Encore Health Resources and Doctors Hospital at Renaissance (DHR) to implement a first-rate, cross-enterprise electronic medical record (EMR) system at the award-winning, Rio Grande Valley health system has earned DHR a high ranking on the Health Information Management & Systems Society (HIMSS) U.S. EMR Adoption Model. From its beginning through "go-live" across DHR's care facilities, the EMR implementation required less than 14 months to successfully accomplish.
ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that it has engaged the Baruch S. Blumberg Institute, the non-profit research sister organization of the Hepatitis B Foundation, to conduct a series of experiments using ContraVir's hepatitis B program, CMX157.
Large-scale food scares like BSE and dioxin-contaminated eggs raised awareness about the health risks posed when a link in the food chain becomes compromised.
The clinical phenotype of COVID-19, caused by SARS-CoV-2, is remarkable for its wide range of severity among individual patients. Genetic variations are known to mediate part of these differences. To examine these differences, researchers in a new study used human induced pluripotent stem cells (iPSCs) from different genetically diverse individuals. These cells are used to model genetic disease since they contain the donor's genetic information. Researchers use a panel of iPSCs from over 500 individuals. The researchers preferred undifferentiated iPSCs to reduce the time required to differentiate them, especially since infection is not always reliable.
› Verified 1 days ago
| Entity Name | Pontchartrain Diagnostic Imaging Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760734685 PECOS PAC ID: 1951552900 Enrollment ID: O20150827002372 |
News Archive
Standard Register today announced its financial results for the fourth quarter and full year 2011. The Company reported revenue of $161.4 million and a net loss of $95.5 million, or $3.28 per diluted share for the fourth quarter of 2011.
Dedication, teamwork, and commitment between Encore Health Resources and Doctors Hospital at Renaissance (DHR) to implement a first-rate, cross-enterprise electronic medical record (EMR) system at the award-winning, Rio Grande Valley health system has earned DHR a high ranking on the Health Information Management & Systems Society (HIMSS) U.S. EMR Adoption Model. From its beginning through "go-live" across DHR's care facilities, the EMR implementation required less than 14 months to successfully accomplish.
ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that it has engaged the Baruch S. Blumberg Institute, the non-profit research sister organization of the Hepatitis B Foundation, to conduct a series of experiments using ContraVir's hepatitis B program, CMX157.
Large-scale food scares like BSE and dioxin-contaminated eggs raised awareness about the health risks posed when a link in the food chain becomes compromised.
The clinical phenotype of COVID-19, caused by SARS-CoV-2, is remarkable for its wide range of severity among individual patients. Genetic variations are known to mediate part of these differences. To examine these differences, researchers in a new study used human induced pluripotent stem cells (iPSCs) from different genetically diverse individuals. These cells are used to model genetic disease since they contain the donor's genetic information. Researchers use a panel of iPSCs from over 500 individuals. The researchers preferred undifferentiated iPSCs to reduce the time required to differentiate them, especially since infection is not always reliable.
› Verified 1 days ago
| Entity Name | Progressive Physician Assoc Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881646859 PECOS PAC ID: 1355243809 Enrollment ID: O20171027001315 |
News Archive
Standard Register today announced its financial results for the fourth quarter and full year 2011. The Company reported revenue of $161.4 million and a net loss of $95.5 million, or $3.28 per diluted share for the fourth quarter of 2011.
Dedication, teamwork, and commitment between Encore Health Resources and Doctors Hospital at Renaissance (DHR) to implement a first-rate, cross-enterprise electronic medical record (EMR) system at the award-winning, Rio Grande Valley health system has earned DHR a high ranking on the Health Information Management & Systems Society (HIMSS) U.S. EMR Adoption Model. From its beginning through "go-live" across DHR's care facilities, the EMR implementation required less than 14 months to successfully accomplish.
ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that it has engaged the Baruch S. Blumberg Institute, the non-profit research sister organization of the Hepatitis B Foundation, to conduct a series of experiments using ContraVir's hepatitis B program, CMX157.
Large-scale food scares like BSE and dioxin-contaminated eggs raised awareness about the health risks posed when a link in the food chain becomes compromised.
The clinical phenotype of COVID-19, caused by SARS-CoV-2, is remarkable for its wide range of severity among individual patients. Genetic variations are known to mediate part of these differences. To examine these differences, researchers in a new study used human induced pluripotent stem cells (iPSCs) from different genetically diverse individuals. These cells are used to model genetic disease since they contain the donor's genetic information. Researchers use a panel of iPSCs from over 500 individuals. The researchers preferred undifferentiated iPSCs to reduce the time required to differentiate them, especially since infection is not always reliable.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jacob Abraham, MD 3520 Piedmont Rd Ne, Suite 250, Atlanta, GA 30305-1516 Ph: (404) 870-2802 | Jacob Abraham, MD 3520 Piedmont Rd Ne, Suite 250, Atlanta, GA 30305-1516 Ph: (404) 870-2802 |
News Archive
Standard Register today announced its financial results for the fourth quarter and full year 2011. The Company reported revenue of $161.4 million and a net loss of $95.5 million, or $3.28 per diluted share for the fourth quarter of 2011.
Dedication, teamwork, and commitment between Encore Health Resources and Doctors Hospital at Renaissance (DHR) to implement a first-rate, cross-enterprise electronic medical record (EMR) system at the award-winning, Rio Grande Valley health system has earned DHR a high ranking on the Health Information Management & Systems Society (HIMSS) U.S. EMR Adoption Model. From its beginning through "go-live" across DHR's care facilities, the EMR implementation required less than 14 months to successfully accomplish.
ContraVir Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced today that it has engaged the Baruch S. Blumberg Institute, the non-profit research sister organization of the Hepatitis B Foundation, to conduct a series of experiments using ContraVir's hepatitis B program, CMX157.
Large-scale food scares like BSE and dioxin-contaminated eggs raised awareness about the health risks posed when a link in the food chain becomes compromised.
The clinical phenotype of COVID-19, caused by SARS-CoV-2, is remarkable for its wide range of severity among individual patients. Genetic variations are known to mediate part of these differences. To examine these differences, researchers in a new study used human induced pluripotent stem cells (iPSCs) from different genetically diverse individuals. These cells are used to model genetic disease since they contain the donor's genetic information. Researchers use a panel of iPSCs from over 500 individuals. The researchers preferred undifferentiated iPSCs to reduce the time required to differentiate them, especially since infection is not always reliable.
› Verified 1 days ago
Omar Nabil Kallas, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1364 Clifton Road, Department Of Radiology And Imaging Sciences, Atlanta, GA 30322 Phone: 404-778-3900 | |
Dr. Bijan Ghorashi, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 20 Glenlake Parkway, Kaiser Permanente Glenlake Medical, Atlanta, GA 30328 Phone: 404-365-0966 Fax: 606-666-6107 | |
Dr. George Oren Atkinson Jr., MD Radiology Medicare: Not Enrolled in Medicare Practice Location: Emory University Hospital, 1364 Clifton Road, Ne, Atlanta, GA 30322 Phone: 404-785-6547 Fax: 404-785-1216 | |
Dr. Fabio P Esteves, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1364 Clifton Rd Ne Radiology, Atlanta, GA 30322 Phone: 404-778-5586 | |
Amy J Figueroa, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1000 Johnson Ferry Rd Ne, Atlanta, GA 30342 Phone: 404-851-8000 | |
Debora Lou Coursey-prah, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1968 Peachtree Rd Nw, Radiology Department, Atlanta, GA 30309 Phone: 404-605-5000 | |
Sachin Parikh, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1365 Clifton Rd Ne, Breast Imaging Center, Winship C, Atlanta, GA 30322 Phone: 404-778-1856 Fax: 404-712-7561 |